[vc_row full_width="0" full_height="0" row_padding="no_bottom_padding" particles="0"][vc_column width="1/2"][vc_column_text css=".vc_custom_1696960967365{margin-bottom: 0px !important;}"]Oral medications under the category of DPP-4 inhibitors commonly treat type 2 diabetes. Dipeptidyl peptidase-4's activity must be blocked for incretin hormones to aggregate. Natural hormones like incretins play a role in regulating blood sugar by prompting insulin release following a meal.
Some examples of DPP-4 inhibitors include:
<ol>
 	<li>Sitagliptin</li>
 	<li>Saxagliptin</li>
 	<li>Linagliptin</li>
 	<li>Alogliptin</li>
 	<li>Teneligliptin</li>
</ol>
Type 2 diabetes medicine containing saxagliptin and alogliptin, FDA analysis discloses, increases heart failure danger among people with pre-existing heart or kidney disorders. Body needs not getting enough blood supply due to heart failure. <strong>Safety issue-related warnings</strong> are being added to drug labels as a result.

Used with diet and exercise, these drugs, including saxagliptin and alogliptin, are part of the DPP-4 inhibitor class of medications for treating type 2 diabetes. The lack of treatment, type 2 diabetes can escalate into direr health circumstances, including blindness, nerve and kidney damage, and heart disease.
Oral tablets, DPP-4 inhibitors are typically taken, which can be used on their own or with other diabetes medications, including metformin or sulfonylureas, to control blood sugar levels. Other diabetes medications carry a greater risk of hypoglycemia, making them a less desirable option compared to these drugs.
The primary<strong> benefits</strong> of DPP-4 inhibitors include:

1. Lowering blood sugar levels: By inhibiting DPP-4, drugs boost incretin hormone amounts, favoring insulin unleash and decreasing glucagon emission to curtail blood sugar surges after meals.

2. Weight neutrality: DPP-4 inhibitors usually do not result in significant weight gain.

3. Low risk of hypoglycemia: Low blood sugar risk is lower with these medications than with some other diabetes treatments.

With any medication, including DPP-4 inhibitors, <strong>potential side effects</strong> must be considered. May include headaches, gastrointestinal issues, and upper respiratory tract infections, common side effects.[/vc_column_text][vc_empty_space][/vc_column][vc_column width="1/2"][vc_empty_space height="10px"][vc_single_image image="2805" img_size="Full"][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height="16px"][/vc_column][/vc_row]